Sakamoto H, Murakawa T, Nishida M
Jpn J Antibiot. 1980 Jun;33(6):675-8.
The competitive effect of ceftizoxime, a new cephalosporin, on in vitro binding of bilirubin to human serum albumin was investigated and compared with that of other beta-lactam antibiotics. At the normal range of the albumin (3.48 g/dl) and bilirubin (0.936 mg/dl) concentrations in the serum of healthy infants, free bilirubin concentration was not increased by adding ceftizoxime and the other beta-lactam antibiotic concentrations tested (up to 640 micrograms/ml). The same results were obtained even under the same condition except that the bilirubin concentration was increased to 10 mg/dl. Under the condition that the albumin concentration decreased to one fifth of the normal concentration, bilirubin was competitively displaced to some extent by adding dicloxacillin (MDIPC), cefazolin (CEZ) and cefmetazole (CMZ) but not by adding ceftizoxime at the concentration of 640 micrograms/ml.
研究了新型头孢菌素头孢唑肟对胆红素与人血清白蛋白体外结合的竞争作用,并与其他β-内酰胺类抗生素进行了比较。在健康婴儿血清白蛋白(3.48 g/dl)和胆红素(0.936 mg/dl)浓度的正常范围内,添加头孢唑肟和其他测试的β-内酰胺类抗生素浓度(高达640微克/毫升)不会增加游离胆红素浓度。即使在相同条件下,将胆红素浓度提高到10 mg/dl,也得到了相同的结果。在白蛋白浓度降至正常浓度五分之一的条件下,添加双氯西林(MDIPC)、头孢唑林(CEZ)和头孢美唑(CMZ)会使胆红素在一定程度上被竞争性取代,但添加浓度为640微克/毫升的头孢唑肟则不会。